Event
MS Intermediate MasterClass 8 – Module 2
Our sponsors
This activity has been supported by sponsorship from Biogen, Roche, Merck and Sanofi. The sponsors have had no control over the educational content of this activity.
Suited to general or non-prescribing neurologists, registrars looking to develop a specialism, pharmacists or established clinical nurse specialists (CNS), this course aims to provide a detailed overview of the modern management of MS across diagnosis and treatment. Module 1 must be attended.
This course will be awarded 30 external CPD credits from the Royal College of Physicians upon completion of Module 2.
Programme
(Version 02/12/2019)
Module 1
Module 1 was held on 12 to 14 June 2019 → click here.
Were you registered on this course?
Log in to access resources..
LoginOur sponsors
This activity has been supported by sponsorship from Biogen, Roche, Merck and Sanofi. The sponsors have had no control over the educational content of this activity.
Speakers
Dr David PalingHonorary strategic director & consultant neurologist, Sheffield Teaching Hospitals NHS Foundation Trust
Prof Jeremy HobartConsultant neurologist, University Hospitals Plymouth
Dr Saúl ReyesConsultant neurologist & honorary clinical lecturer, Queen Mary University of London
Dr John ThorpeConsultant neurologist, Addenbrooke’s Hospital, Cambridge and Peterborough City Hospital
Prof Ruth DobsonCentre lead, professor of clinical neurology & consultant neurologist, Centre for Preventive Neurology & Wolfson Institute of Population Health, Queen Mary University of London
Encouraging excellence, developing leaders, inspiring change
MS Academy was established in 2016 and in that time has accomplished a huge amount with exciting feedback demonstrating delegates feel inspired and energised along their personal and service development journeys. The various different levels of specialist MS training we offer are dedicated to case-based learning and practical application of cutting edge research.